-
Why Senseonics Shares Are Rocketing Higher After Hours Thursday
Thursday, June 3, 2021 - 4:58pm | 326Read More...Study results from a glucose monitoring company were reported after market close Thursday. What Happened: Medical technology company Senseonics Holdings (NYSE: SENS) reported results from a PROMISE study evaluating its Eversense CGM System for up to 180 days. The Eversense CGM is a continuous...
-
BMO Adds Boston Scientific To Top Picks, Sees Catalysts Ahead
Thursday, May 30, 2019 - 1:27pm | 441Read More...Boston Scientific Corporation (NYSE: BSX) delivered a first-quarter miss in April and adjusted its 2019 guidance. The stock holds several catalysts this year, including the FDA paclitaxel panel, a pipeline update at the company’s analyst meeting in June and the closing of the BTG...
-
CAS Medical Surges As Edwards Lifesciences Agrees To Buy Medtech Company In $100M Deal
Tuesday, February 12, 2019 - 11:50am | 402Read More...CAS Medical Systems Inc (NASDAQ: CASM) shares are rising by one-half of their value Tuesday after Edwards Lifesciences Corp (NYSE: EW), a manufacturer of heart valves and other medical devices, announced an agreement to buy the company. What Happened CAS Medical is a medical tech company...
-
BofA: Medtronic's Growth 'Should Continue To Surprise'
Wednesday, August 22, 2018 - 3:18pm | 391Read More...Medical device maker Medtronic PLC (NYSE: MDT)'s rocketed higher after the company reported first-quarter earnings Tuesday. The Analyst Bank of America Merrill Lynch analyst Bob Hopkins reiterated a Buy rating on Medtronic and increased the price target from $98 to $105. The...
-
BTIG Turns Neutral On TransEnterix, Says Stock Rally Unsupported By Fundamentals
Thursday, June 28, 2018 - 12:25pm | 380Read More...Transenterix Inc (NYSE: TRXC) shares have spiked 50 percent in the last week, 71 percent in the last month and 734 percent in the last year. But one analyst senses diminishing momentum. The Rating BTIG analyst Sean Lavin downgraded TransEnterix to Neutral and withdrew his price target. The...
-
KeyBanc Initiates Becton, Dickinson And Co. With Bullish Stance
Friday, January 5, 2018 - 11:16am | 374Read More...Becton Dickinson and Co (NYSE: BDX) was initiated with a top-notch rating by KeyBanc Capital Markets Thursday. The Analyst KeyBanc analyst Matthew Mishan initiated coverage on Becton Dickinson with an Overweight and $260 price target. The Thesis "We believe [the company] is...
-
Cooper Companies Third Quarter Good, Not Great, Says BMO
Friday, September 2, 2016 - 11:25am | 338Read More...Cooper Companies Inc (NYSE: COO) reported its third-quarter results after Thursday's market close. The company said it earned $2.30 per share in the quarter on revenue of $514.7 million, exceeding the $2.29 per share and $511.8 million Wall Street analysts were expecting. According to Joanne...
-
Exclusive: Cytosorbents CEO On How Its Blood Purification Technology Can Change Healthcare
Monday, August 15, 2016 - 8:54am | 611Read More...Cytosorbents Corp (NASDAQ: CTSO) is a critical care focused immunotherapy company that focuses on the commercializing its main product, CytoSorb - a blood purification technology which focuses on preventing or treating multiple organ failures. Benzinga had the opportunity to chat with the...
-
Greatbatch Announces Spinoff Of QiG Group, Highlights 'Important Milestone' In Growth Strategy
Wednesday, February 24, 2016 - 3:48pm | 228Read More...Greatbatch Inc (NYSE: GB), a manufacturer of medical devices and components, announced on Wednesday that its Board of Directors approved the spinoff of its QiG Group, a research and development organization that focuses on the Cardiovascular, Neuromodulation and Orthopaedics markets. QiG Group...
-
Johnson & Johnson Details $1 Billion Cost Saving Initiative For Its Medical Devices Segment, Will 'Deliver More Value To Customers'
Tuesday, January 19, 2016 - 4:24pm | 251Read More...Shares of Johnson & Johnson (NYSE: JNJ) were trading higher by 0.26 percent at $97.25 early Tuesday afternoon after the company detailed a $1 billion cost saving initiative for its Medical Devices business. Johnson & Johnson stated that it will eliminate approximately 4 to 6 percent of its...
-
UV Flu Technologies (OTCBB: UVFT) Announces Growth of National Distributor Network for UV-400
Tuesday, November 2, 2010 - 12:35pm | 941Read More...CENTERVILLE, MA – November 2, 2010 (Investorideas.com Newswire) - UV Flu Technologies, Inc. (OTCBB: UVFT) (the "Company") is pleased to announce the recent signing of agreements with 3 new distributors to commence offering the ViraTech UV-400 to their market segment commercial accounts. The new...
